Fast-neutron radiobiology and radiotherapy.
The application of fast neutrons, negative pions or heavy ions will only provide an advantage for the radiotherapy of cancer if, in comparison with conventional radiations, e.g., X-rays, gamma rays and electrons, better depth-dose and collimation characteristics or specific radiobiological dose response relationships result in greater local control probabilities for tumours without increased frequencies of severe noraml tissue damage. Differences in intrinsic radiosensitivity and the presence of hypoxic cells are considered to be the main factors which can cause values of the relative biological effectiveness (RBE) for responses of tumours to be larger than RBE values for normal tissue tolerance. Clinical studies on lung metastases irradiated with single dose of 15 MeV neutrons indicate that RBE values for tumour growth delay can vary between 1.2 and 4.0, while RBE values for damage to several normal tissues are estimated from corresponding animal data to be approximately 2.5.
D004307:Dose-Response Relationship, Radiation; D004735:Energy Transfer; D005214:Fast Neutrons; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D009502:Neutrons; D011853:Radiobiology / Q000295:instrumentation*; D011878:Radiotherapy / Q000295:instrumentation*